GLP-1 Benefits, Risks Detailed in ‘Atlas’ Mapping Outcomes

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without randomization, caution urged in interpretation.
Medscape Medical News